There is increasing evidence that the nervous system has in£u-ence on the immune response. The e¡ect of vasoactive intestinal peptide (VIP) and of serotonin and its antagonists on the challenge phase of allergic contact dermatitis in humans were tested. The substances were injected intracutaneously shortly before and 6 h after application of patch tests with nickel sulphate in nickel-allergic patients and the test areas were measured after a further 18 h. Biopsy specimens were also taken for immunohistochemistry. The diameter of the nickel sulphate-induced test reaction was signi¢cantly reduced after injection of VIP at 10 À6^1 0 À5 mol/l, but was not a¡ected by serotonin or ketanserin. Also tested was the in£uence of the substances on the response of peripheral blood mononuclear cells from nickel-allergic subjects to nickel sulphate, when added at the same time as the antigen. No e¡ect on the cell proliferative rate was seen, except for an inhibitory e¡ect of serotonin and its antagonists at 10 À5^1 0 À4 mol/l. VIP, at 10 À5 mol/l and serotonin at 10 À4 mol/l stimulated the secretion of interferon gamma. The interleukin-2 soluble receptor secretion was slightly stimulated by 5-HT at 10 À4 mol/l and by ketanserin at 10 À6 mol/l. In conclusion, our results show that when injected intracutaneously in the challenge phase of allergic contact dermatitis, VIP has an inhibitory e¡ect, which might be explained by enhanced leukocyte production of interferon gamma.
There is increasing evidence that the nervous system has in£u-ence on the immune response. The e¡ect of vasoactive intestinal peptide (VIP) and of serotonin and its antagonists on the challenge phase of allergic contact dermatitis in humans were tested. The substances were injected intracutaneously shortly before and 6 h after application of patch tests with nickel sulphate in nickel-allergic patients and the test areas were measured after a further 18 h. Biopsy specimens were also taken for immunohistochemistry. The diameter of the nickel sulphate-induced test reaction was signi¢cantly reduced after injection of VIP at 10 À6^1 0 À5 mol/l, but was not a¡ected by serotonin or ketanserin. Also tested was the in£uence of the substances on the response of peripheral blood mononuclear cells from nickel-allergic subjects to nickel sulphate, when added at the same time as the antigen. No e¡ect on the cell proliferative rate was seen, except for an inhibitory e¡ect of serotonin and its antagonists at 10 À5^1 0 À4 mol/l. VIP, at 10 À5 mol/l and serotonin at 10 À4 mol/l stimulated the secretion of interferon gamma. The interleukin-2 soluble receptor secretion was slightly stimulated by 5-HT at 10 À4 mol/l and by ketanserin at 10 À6 mol/l. In conclusion, our results show that when injected intracutaneously in the challenge phase of allergic contact dermatitis, VIP has an inhibitory e¡ect, which might be explained by enhanced leukocyte production of interferon gamma. Key words: 5-HT; nickel sulphate; immunohistochemistry; lymphocyte transformation; ELISA. There is increasing evidence that neuropeptides and monoamines modulate various kinds of in£ammation and delayedtype hypersensitivity (1^3). In several studies using animal models the e¡ects of neuroactive substances on the challenge phase of the delayed-type hypersensitivity reaction have been evaluated (4, 5) . Vasoactive intestinal peptide (VIP) has been found to have an inhibitory e¡ect on the delayed type hypersensitivity reaction in mice when infused subcutaneously, from 3 days before to 3 days after challenge (6) . In vivo treatment of skin-sensitized mice with ketanserin (a serotonin (5-hydroxytryptamine, 5-HT) antagonist) inhibited their capacity to elicit a delayed-type hypersensitivity reaction and the ability of their lymphoid cells to transfer delayed-type hypersensitivity (7) .
In a previous study (8) we observed that topical application of VIP at a concentration of 10 À5 mol/l caused a reduction in the diameter of an established test reaction to nickel sulphate in humans. In addition, CD4z cells were reduced in number. Ketanserin at 10 À4 mol/l also reduced the diameter of the test reaction. An increased production of interferon gamma was found when VIP, at 10 À5 and 10 À6 mol/l, was added to proliferating nickel-stimulated peripheral blood mononuclear cells from nickel-allergic patients.
To further investigate the modulatory e¡ect of VIP, 5-HT and its antagonists on the challenge phase of allergic contact dermatitis in humans, these neuroactive substances were injected intracutaneously before and after application of nickel sulphate for 6 h in nickel-sensitive patients. In addition, peripheral blood mononuclear cells from nickel-allergic patients were cultured with nickel sulphate together with the substances, added at the same time as the antigen. The cell proliferation was measured and the supernatants were analysed by ELISA for their concentrations of interferon gamma, interleukin (IL)-2, IL-2 soluble receptor (IL-2sR) and IL-4.
MATERIALS AND METHODS

Patients
Thirty female patients (age range 22^55 years) with patch test-veri¢ed allergic contact dermatitis from nickel sulphate participated in this investigation. The study was approved by the local Medical Ethics Committee at the Karolinska Hospital, Stockholm, Sweden. All subjects had zzz positive patch test reactions (erythema, oedema, papules and vesicles), as according to the International Contact Dermatitis Research Group (ICDRG) (9) .
Test substances
Nickel sulphate was obtained from Merck (Darmstadt, Germany). When used for patch testing it was dissolved in distilled water to a concentration of 5.0%. For the lymphocyte proliferation test it was dissolved in 0.9% saline to a concentration of 3.8610 À5 mol/l, which had previously been found to be optimal (10) .
Native VIP was puri¢ed from porcine upper intestine by sequential chromatography and countercurrent distribution, as described previously (11) and was found to be homogeneous by high performance liquid chromatography and capillary electrophoresis.
5-HT was obtained from Sigma (St Louis, MO, USA), ketanserin (a speci¢c 5-HT 2 receptor blocker) from Janssen Pharmaceutica (Beerse, Belgium), methiotepin (a blocker of both 5-HT 1c and 5-HT 2 receptors) from Ho¡man-La Roche (Basel, Switzerland) and tropisetron (ICS-205-930, a blocker of 5-HT 3 ) from Sandoz (Basel, Switzerland).
VIP, 5-HT, ketanserin, methiotepin and tropisetron were dissolved in saline and used for intracutaneous administrations at concentrations of 10 À4^1 0 À7 mol/l and in the cell cultures at ¢nal concentrations of 10
À4^1
0
À11 mol/l.
Patch testing procedure
The experimental design is summarized in Fig. 1 . VIP (n~8), 5-HT (n~3) and ketanserin (n~7) were injected intracutaneously (i.c.) in normal skin on the upper part of the patients' backs. The volume injected was 50 ml. 5-HT was only tested in 3 patients and methiotepin and tropisetron were only tried in a pilot study (not shown). It was not possible to use these latter mediators as the patients felt a sharp pain when the solutions were injected. VIP was used at a concentration of 10 À5^1 0 À7 mol/l, and 5-HT and ketanserin at 10 À4^1 0 À6 mol/l. Saline was used as control. On the same site as the i.c. injection, patch tests with 5% nickel sulphate in distilled water, in a volume of 15 ml, were performed with Finn chambers (Epitest, Helsinki, Finland), using polypropylene coated aluminium discs with ¢lters on Scanpor tape (Norgeplaster A/S, Oslo, Norway). After 6 h the Finn Chambers with nickel sulphate were removed and again the neuroactive substances or saline were injected with the same procedure as before. After an additional 18-h period the test reactions were measured. Two investigators independently measured the intensity of the test reactions, using the scoring system recommended by the ICDRG, and the maximal diameters of the test reactions, one of the investigators blindly.
Immunohistochemical studies
Biopsy specimens were taken from the test areas for immunohistochemistry after anaesthesia with lidocaine without adrenalin. Each specimen was immediately frozen in liquid nitrogen and stored at^70³C until used. Acetone-¢xed cryostat sections, 6 mm thick, were stained with a two-stage monoclonal antibody peroxidase method (12) . The panel of the mouse monoclonal antibodies (MAbs) contained Leu 2a (CD 8, T cytotoxic/suppressor cells), Leu 3a (CD 4, T helper/inducer cells), Leu 6 (CD 1a, Langerhans' cells), HLA-DR (activated T-cells, B cells, macrophages, monocytes and Langerhans' cells) and IL-2 receptor (CD 25). These antibodies were all from Becton Dickinson (San Jose¨, CA, USA) and the working dilution was 1 : 100. In addition, expression of intercellular adhesion molecule-1 (ICAM-1, CD 54) was examined with a mouse monoclonal antibody obtained from Serotec (Oxford, UK), used at 1 : 60. Three sections per antibody and biopsy specimen were examined. The estimation of the total number of cells per section reactive to the di¡erent monoclonal antibodies was based on a semi-quantitative scale (^no positive cells, z few, zz moderate number, zzz many). The size of the in¢ltrates and the degree of spongiosis in the epidermis were also measured with a semi-quantitative scale, with evaluation of the in¢ltrates as small, medium or large, and the spongiosis as light, medium or heavy. Two investigators examined all the slides independently of each other and the mean values were recorded. The slides were coded to avoid observer bias.
Lymphocyte transformation test
Peripheral blood mononuclear cells were obtained from heparinized blood from 6 of the 30 nickel-allergic patients. The cells were separated on Percoll gradients on the basis of buoyant density (13) (density of stock solution 1.129 g/ml; Pharmacia Fine Chemicals, Uppsala, Sweden). They were then cultured in RPMI 1640 medium (Life Technologies, Ta« by, Sweden) with addition of L-glutamine (2 mmol/ml), streptomycin (100 mg/ml), penicillin (100 IU/ml) and 10% heat-inactivated human AB serum at a concentration of 2610 6 cells/ml. The cells were subsequently incubated in 100 ml cultures for 6 days in a Linbro microtitration plate at 37³C in an atmosphere of 5% CO 2 in air. After preincubation for 30 min, 20 ml of the nickel sulphate solution was added. After another 30 min, VIP, 5-HT and 5-HT antagonists were added in a volume of 20 ml and with saline as control. Six hours before interruption of the cultures, 0.5 mCi of 3 H-thymidine (5 Ci/mmol; Amersham International, Amersham, UK) in 10 ml saline was added to each well. The cells were then collected on glass ¢bre ¢lters using a Skatron multiple-cell collector. Radioactivity was determined by counting in a Packard liquid scintillation spectrometer. The proliferative rate was measured in counts per minute (cpm). The cultures were performed in triplicate.
Interferon gamma and IL-4 assay
On the 6th day of incubation with nickel sulphate and the neuroactive substances, supernatants were obtained from the peripheral blood mononuclear cell cultures and immediately stored at^70³C. The concentrations of interferon gamma and IL-4 were determined by a sandwich ELISA (Pharmingen, San Diego, CA, USA), following the recommendation of the manufacturer. Brie£y, £at bottom high binding plates (Costar, Cambridge, MA, USA) were coated, by incubation overnight at 4³C, with anticytokine MAbs diluted in binding solution, 50 ml per well. Sites for non-speci¢c binding of protein were blocked with PBS/10% foetal calf serum (FCS), 200 ml per well, for 30 min (interferon gamma) or for 2 h (IL-4). Samples in duplicate and medium blanks were added, 100 ml per well, and a standard curve was constructed for each plate and incubated overnight. After washing, a biotinylated anticytokine detection MAb, diluted in PBS/10% FCS, was added in a volume of 100 ml per well. After incubation for 1 h at room temperature, 100 ml of avidin-peroxidase (Sigma, St Louis, MO, USA, 1 : 400 dilution of a 1 mg/ml stock solution) per well was added and the plates were incubated at room temperature for 30 min. For detection, the peroxidase substrate 2,2'-azino-bis (3-ethylbenz-thiazoline-6-sulphonic acid) (ABTS) (Sigma) was used. The plates were read within 30 min at a wavelength of 405 nm by an ELISA reader (Vmax, Molecular Device Corporation, CA, USA).
IL-2 assay
After 48 h of incubation the concentrations of IL-2 were determined by a Duo Set ELISA (Genzyme Diagnostics, Cambridge, MA, USA), using the protocol supplied by the manufacturer. In brief, Costar plates were coated with capture antibody diluted in 0.1 M sodium carbonate, pH 9.5, 100 ml per well, and incubated overnight at 4³C. The plates were blocked with 4% bovine serum albumin in PBS, pH 7.3, 0.01 M, 250 ml per well and incubated for 2 h at 37³C. After washing diluted standards and samples in duplicate were added, 100 ml per well, and incubated for 1 h at 37³C. A volume of 100 ml of the diluted second antibody was then added and incubated for 1 h at 37³C. After this step 100 ml per well of the diluted detecting reagent was added and incubated for 15 min at 37³C. Finally tetramethyl benzidine and hydrogen peroxidase were added, 100 ml per well, and incubated for 10 min at room temperature. The plates were read at 450 nm within 30 min.
IL-2sR assay
At 2 days the concentrations of soluble IL-2sR were measured by ELISA using the human IL-2sR Immunoassay Quantikine kit (R&D Systems, Minneapolis, MN, USA), as recommended by the manufacturer. The plates were read at 450 nm.
Statistical analysis
Analyses of variance for repeated measurements (ANOVA) were used for statistical analyses. In order to determine the signi¢cance level in the pairwise comparisons, the method proposed by Dunnett was used (14) . Fig. 1 . VIP, serotonin and the serotonin antagonist ketanserin were tested in the challenge phase of allergic contact dermatitis in humans. The neuroactive substances were injected intracutaneously on the backs of patients allergic to nickel. On the same site nickel sulphate was applied under patch test conditions for 6 h. The patch tests were removed and the neuroactive substances and saline were injected again. The diameters of the test reactions were measured after 24 h.
RESULTS
Patch testing
The diameter of the nickel sulphate-induced test reaction was signi¢cantly reduced (pv0.05) after injection of VIP at concentrations of 10 À5 and 10 À6 mol/l ( Fig. 2 and 3) , however, no e¡ect on the ICDRG scores was found. No e¡ect was observed with 5-HT or ketanserin.
Immunohistochemical studies
The histological picture was typical for in£ammation in allergic contact eczema, with in¢ltrates of mononuclear cells in the dermis and spongiosis of the epidermis. In the in¢ltrates there was a predominance of CD4z cells. HLA-DR was upregulated on the in¢ltrating cells, as well as ICAM-1, which was also found adjacent to the vessels and in the epidermis. Sometimes keratinocyte HLA-DR expression was also seen.
There were no di¡erences in the number of di¡erent phenotypes of the in¢ltrating cells or in the size of the cellular in¢l-trate, or the degree of spongiosis, after injection of VIP, 5-HT and ketanserin. Neither did the number of cells with expression of IL-2 receptor or of HLA-DR show any di¡erence and there was no di¡erence in the epidermal level of ICAM-1 expression between neuroactive substance-treated and control skin (not shown).
DNA synthesis
Compared with saline, nickel sulphate had a distinct stimulatory e¡ect on the proliferative response of the blood mononuclear cells, with a wide individual variation (1, 144^28, 200 cpm). VIP had no e¡ect on the proliferative response, while 5-HT, ketanserin and tropisetron each had an inhibitory e¡ect at 10 À4 mol/l (pv0.05). Methiotepin had an inhibitory e¡ect at 10 À4 and 10 À5 mol/l (pv0.05).
Interferon gamma secretion
There was a wide individual variation in the values for interferon gamma secretion when nickel sulphate was added together with saline, with a range of 85^668 pg/ml. VIP, at a Fig. 3 . One of the nickel-allergic patients with patch test-induced reactions modulated with di¡erent concentrations (mol/l) of VIP and saline (control). concentration of 10 À5 mol/l, and 5-HT, at 10 À4 mol/l, had a signi¢cant (pv0.05) stimulatory e¡ect on the secretion of interferon gamma (Fig. 4 and 5) . Ketanserin had no e¡ect, while methiotepin and tropisetron showed an inhibitory e¡ect at 10 À4 mol/l (pv0.05) (not shown).
COLOUR FIGURE
IL-2 secretion
The IL-2 concentrations also varied considerably. When nickel sulphate and saline were added, the values ranged from 45 to 1,159 pg/ml. VIP, 5-HT, ketanserin and tropisetron had no e¡ect on the secretion of IL-2. Methiotepin had an inhibitory e¡ect at 10 À4 mol/l (pv0.05) (not shown).
IL-2sR secretion
The secretion of IL-2sR after addition of nickel sulphate and saline varied from 66 to 276 pg/ml. VIP had no e¡ect on this secretion, while 5-HT (10 À4 mol/l) and ketanserin (10 À6 mol/l) showed a slight stimulatory e¡ect. Methiotepin and tropisetron had an inhibitory e¡ect at 10 À4 mol/l (pv0.05) (not shown).
IL-4 secretion
The concentrations of IL-4 were very low when nickel sulphate and saline were added, and all values were below 20 pg/ml. The neuroactive substances had no e¡ects (not shown).
DISCUSSION
In the present study, VIP, at 10
À5^1
0
À6 mol/l, injected intracutaneously before and after the application of nickel sulphate by the patch testing procedure in nickel-allergic patients, caused a signi¢cant reduction in the diameter of the test reaction. It had no e¡ect on the size of the in¢ltrate, the grade of spongiosis or the phenotypes of the in¢ltrating mononuclear cells. The secretion of interferon gamma was increased when VIP was added at 10 À5 mol/l. VIP had no e¡ect on the secretion of IL-2, IL-2sR or IL-4, or on the proliferative response.
VIP has been found to have a protective e¡ect against in£ammatory injury or toxicity due to a variety of agents (15^17). It has also shown protective e¡ects on lymphocytes against metal toxicity (18) . Bandypadhyay et al. (19) concluded that VIP may play a signi¢cant protective role in the gastrointestinal tract against the damaging e¡ects of nitric oxide induced by cytotoxic agents. In a murine model of in£amma-tion in lung parenchyma, VIP exerts a late dampening e¡ect on the pulmonary immune response (20) .
VIP is known to have an inhibitory action on the proliferation of T lymphocytes and also on the IL-2 production in murine splenic or lymph node T lymphocytes stimulated with concanavalin A (Con A) (21^23). Few studies have used antigen-sensitized T-cells, as we have done in this investigation. Using antigen-sensitized T-cells, Nio et al. (24) did not ¢nd any signi¢cant e¡ect of VIP, substance P (SP) or somatostatin upon the proliferation of AO40.1 cells. VIP stimulated the IL-2 release at low concentrations in this system, with a marked e¡ect at 10 À14 mol/l. Interferon gamma is another cytokine responsible for the Th1 response, known to be involved in the delayed-type hypersensitivity reaction. VIP has been reported not to a¡ect interferon gamma production by murine T lymphocytes stimulated with Con A, anti-CD3, or anti-CD3 plus phorbol 12-myristate-13-acetate (PMA) (23, 25) . However, human peripheral blood lymphocytes stimulated with the polyclonal activator staphylococcal enterotoxin A showed a reduced production of interferon gamma with a maximum e¡ect with VIP at 10 À8^1 0 À9 mol/l (26). It has been suggested that interferon gamma may be important, either directly or indirectly, in both the initial resistance to and the resolution of infection with cryptosporiosis in mice (27) . Interferon gamma also assists in the resolution of in£am-mation, partly by induction of apoptosis in lymphocytes (28) . Scheynius & Skoglund (29) showed that interferon gamma may upregulate or downregulate the immune response depending on the pathological state of the recipient. In their study a pronounced reduction of the in£ammatory response was observed when interferon gamma was given prior to elicitation. This might possibly explain our ¢ndings that VIP reduced the diameter of the test reaction, as an e¡ect exerted through stimulation of the interferon gamma production by the leukocytes. Interferon gamma may have a dual role in the allergic contact reaction, upregulation of the immune response in the sensitization phase and downregulation in the elicitation or challenge phase.
The negative e¡ect of VIP in the immunohistochemistry study might be explained by the fact that the patients only had patch tests with nickel sulphate for 6 h instead of 48 h. The number of in¢ltrating in£ammatory cells producing cytokines does not reach a maximum before this latter time point (30) .
We found that serotonin and its antagonists at a concentration of 10 À4 mol/l (also methiotepine at 10 À5 mol/l) had an inhibitory e¡ect on the cell proliferation. This e¡ect has previously been found to be toxic, as judged by the uptake of try- Fig. 5 . The concentrations of interferon gamma (pg/ml) were measured by ELISA in the supernatants of lymphocyte cultures on day 6 of stimulation by nickel sulphate. 5-HT at di¡erent concentrations was added at the beginning of the culture. Each value represents the mean value (¡SEM) of 6 experiments. Di¡erence from control at *pv0.05. pan blue (8) . The most pronounced inhibition was observed with methiotepin and tropisetron.
In the present study, serotonin at a concentration of 10 À4 mol/l signi¢cantly stimulated the secretion of interferon gamma and IL-2sR. Serotonin has been reported to promote the production of interferon gamma in natural killer cells in the presence of monocytes (31) . Serotonin has also shown a stimulatory e¡ect on murine splenic T-cells, with enhanced proliferation and IL-2 production (32). Production of Th1 cytokines, such as IL-2 and interferon gamma, by antigen-stimulated immune murine spleen cells is inhibited by 5-HT receptor antagonists in vitro (33) . In the present investigation we noted that ketanserin caused a small increase in IL-2sR. This may be due to some agonistic e¡ect of this serotonin antagonist.
In conclusion, our results indicate that VIP, when injected intracutaneously in the challenge phase of allergic contact ermatitis, has an inhibitory e¡ect, possibly mediated by an enhanced leukocyte production of interferon gamma. This hypothesis for the mechanism of the immunomodulatory role of VIP needs further investigation.
